Sentynl Therapeutics
CA - Solana BeachBiotechnology
Focus: Sentynl Therapeutics is a public-stage biotech company focused on small-molecule therapeutics across neurology, oncology, and rare diseases. The company maintains a marketed portfolio including rare disease treatments and pain management products.
Profile data last refreshed 3h ago · AI intelligence enriched 3w ago
Funding Stage
PUBLIC
Open Jobs
0
About Sentynl Therapeutics
AI assessmentNot HiringNo open roles listed right now. Follow Sentynl Therapeutics to get notified when they start hiring — the background below is worth knowing for when they do.
Generated by Claude from Sentynl Therapeutics's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.
Data completeness
5/9 — Partial
Company HealthSolid
Pipeline
Early-stage
2 total
LOE Risk
3 in 5yr
NULIBRY
Hiring
0 open
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Key Products
Stable
Growth4.2yr
Recently launched NDA-approved product with extended exclusivity; core asset in rare metabolic disease franchise.
Help build intelligence for Sentynl Therapeutics
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.